A Comprehensive Review of Treatment Approaches and Perspectives for Management of Rheumatoid Arthritis

E. Alum, U. Ibiam, Ugwu Okechukwu Paul-Chima
{"title":"A Comprehensive Review of Treatment Approaches and Perspectives for Management of Rheumatoid Arthritis","authors":"E. Alum, U. Ibiam, Ugwu Okechukwu Paul-Chima","doi":"10.59298/inosrsr/2023/2.2.13322","DOIUrl":null,"url":null,"abstract":"Rheumatoid arthritis (RA) is an inflammatory illness that mostly affects the joints, although it can also affect other organs and limit movement. This symmetrical, chronic illness typically manifests between the ages of 35 and 60 and causes joint degradation, pain, and systemic symptoms. Because of their different clinical manifestations, RA and osteoarthritis must be distinguished from one another. Osteoarthritis is caused by wear and tear, whereas RA is symmetrical and involves an immunological response. The goals of RA management are to lessen discomfort, reduce inflammation, and avoid joint deformities and destruction because there is currently no known treatment for RA. A combination of medication, specialized exercise, education, and rest are used in treatment plans, taking into account the disease's course, the joints that are impacted, and the patient's general health. The two main forms of treatment are corticosteroids and nonsteroidal anti-inflammatory medications (NSAIDs), which reduce inflammation and discomfort but frequently present varying side effects. Disease modifying anti-rheumatic medications commonly called DMARDs, provide a backup plan by delaying the deterioration of joints and easing associated symptoms. Modern treatment options include methotrexate, hydrochloroquine, and more recent drugs like leflunomide and biologics like interleukin inhibitors and tumor necrosis factor (TNF) inhibitors, each with unique advantages and disadvantages. In order to improve joint function and reduce discomfort, surgical interventions—which have become less common as a result of medical advancements are taken into consideration for severe cases or end-stage RA. Physcial and occupational therapy, nutritional supplements, complementary therapies, and current molecular mechanism research provide further options for controlling RA symptoms and enhancing the quality of life for patients. This review offers a thorough analysis of both traditional and contemporary RA treatments, emphasizing the need for a multimodal strategy to effectively manage the disease and pointing out possible directions for future research and development. Keywords: Autoimmune disease, Rheumatoid arthritis, Disease-modifying drugs, Joint degradation, Osteoarthritis, Joint pain.","PeriodicalId":510166,"journal":{"name":"INOSR Scientific Research","volume":" 66","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"INOSR Scientific Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.59298/inosrsr/2023/2.2.13322","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Rheumatoid arthritis (RA) is an inflammatory illness that mostly affects the joints, although it can also affect other organs and limit movement. This symmetrical, chronic illness typically manifests between the ages of 35 and 60 and causes joint degradation, pain, and systemic symptoms. Because of their different clinical manifestations, RA and osteoarthritis must be distinguished from one another. Osteoarthritis is caused by wear and tear, whereas RA is symmetrical and involves an immunological response. The goals of RA management are to lessen discomfort, reduce inflammation, and avoid joint deformities and destruction because there is currently no known treatment for RA. A combination of medication, specialized exercise, education, and rest are used in treatment plans, taking into account the disease's course, the joints that are impacted, and the patient's general health. The two main forms of treatment are corticosteroids and nonsteroidal anti-inflammatory medications (NSAIDs), which reduce inflammation and discomfort but frequently present varying side effects. Disease modifying anti-rheumatic medications commonly called DMARDs, provide a backup plan by delaying the deterioration of joints and easing associated symptoms. Modern treatment options include methotrexate, hydrochloroquine, and more recent drugs like leflunomide and biologics like interleukin inhibitors and tumor necrosis factor (TNF) inhibitors, each with unique advantages and disadvantages. In order to improve joint function and reduce discomfort, surgical interventions—which have become less common as a result of medical advancements are taken into consideration for severe cases or end-stage RA. Physcial and occupational therapy, nutritional supplements, complementary therapies, and current molecular mechanism research provide further options for controlling RA symptoms and enhancing the quality of life for patients. This review offers a thorough analysis of both traditional and contemporary RA treatments, emphasizing the need for a multimodal strategy to effectively manage the disease and pointing out possible directions for future research and development. Keywords: Autoimmune disease, Rheumatoid arthritis, Disease-modifying drugs, Joint degradation, Osteoarthritis, Joint pain.
类风湿关节炎的治疗方法和管理前景综述
类风湿性关节炎(RA)是一种炎症性疾病,主要影响关节,但也会影响其他器官并限制活动。这种对称性慢性疾病通常在 35 岁至 60 岁之间发病,会导致关节退化、疼痛和全身症状。由于临床表现不同,RA 和骨关节炎必须相互区分。骨关节炎是由磨损引起的,而 RA 是对称性的,涉及免疫反应。RA 的治疗目标是减轻不适、减少炎症、避免关节畸形和破坏,因为目前还没有已知的 RA 治疗方法。在治疗计划中,将药物、专门锻炼、教育和休息结合起来使用,同时考虑到疾病的过程、受影响的关节以及患者的总体健康状况。皮质类固醇和非甾体抗炎药物(NSAIDs)是两种主要的治疗方式,它们可以减轻炎症和不适,但经常会产生不同的副作用。改变病情的抗风湿药物通常称为 DMARDs,通过延缓关节退化和缓解相关症状提供备用方案。现代治疗方案包括甲氨蝶呤、氢氯喹、来氟米特等最新药物以及白细胞介素抑制剂和肿瘤坏死因子(TNF)抑制剂等生物制剂,每种药物都有其独特的优缺点。为了改善关节功能和减轻不适,严重病例或终末期RA患者会考虑手术治疗,但随着医疗技术的进步,手术治疗已不再常见。物理和职业疗法、营养补充剂、辅助疗法以及当前的分子机制研究为控制RA症状和提高患者生活质量提供了更多选择。本综述对传统和现代的 RA 治疗方法进行了深入分析,强调了采取多模式策略有效控制疾病的必要性,并指出了未来研究和发展的可能方向。关键词自身免疫性疾病 类风湿关节炎 改变病情药物 关节退化 骨关节炎 关节疼痛
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信